Robert Josse
Dr R Josse graduated In Medicine with Honours from the University of London. He undertook Postgraduate Training at various Teaching Hospitals at the University of London UK and completed his Endocrine Clinical Training in Canada, after which he did a Research Fellowship at the University of Toronto followed by a further Clinical Fellowship at the Massachusetts General Hospital. He holds Fellowships in Internal Medicine from the American College of Physicians, Royal College of Physicians of London and Internal Medicine and Endocrinology Fellowship from the Royal College of Physicians of Canada. He is also a fellow of the American College of Endocrinology.
He is a Full Professor in the Departments of Medicine and Nutritional Sciences It the University of Toronto. He is a past Head of the Division of Endocrinology and Metabolism and has completed a term as Associate Physician-in-Chief al St Michael's Hospital He is the Director of the Metabolic Bone Disease and Osteoporosis Centre at St. Michael's Hospital He is an adjunct scientist at the Li Ka Shing Knowledge Translation Centre. He is a consultant to (and a past Chair of) the Scientific Advisory Council of Osteoporosis Canada. He is a past President of the Canadian Society of Endocrinology and Metabolism (CSEM). He is the past chair of the CHE development and e-CME committee of CSEM. He received the 2007 Distinction in Clinical Endocrinology Award from the American College of Endocrinology and the 2007 Robert Volpe Distinguished Service Award of the Canadian Society of Endocrinology and Metabolism He is also the recipient of the Lindy Fraser Founder award of Osteoporosis Canada. He was awarded the 2012 Queen Elizabeth II Diamond Jubilee Medal for significant achievement and remarkable service to osteoporosis research and treatment in 2014 he received the educator of
the year award from the CSEM.
His major clinical and research interests include osteoporosis, metabolic bone disease and calcium metabolism as well as diabetes and various nutritional metabolic problems His unit is involved with phase two and three clinical drug trials with funding from pharma. He has also received collaborative funding from other agencies including CIHR, CDA and NCI. He has co-authored over two hundred and eighty articles In peer reviewed Journals, an osteoporosis and a diabetes (with colleagues at the University of Montreal) book of patients and twenty-one book chapters He lectures widely both nationality and internationally on various endocrine and metabolic topics.